Single-cell Analysis Technologies for Immuno-oncology Research: from Mechanistic Delineation to Biomarker Discovery
The successes with immune checkpoint blockade (ICB) and chimeric antigen receptor (CAR)-T-cell therapy in treating multiple cancer types have established immunotherapy as a powerful curative option for patients with advanced cancers. Unfortunately, many patients do not derive benefit or long-term re...
Main Authors: | Zhiliang Bai, Graham Su, Rong Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Genomics, Proteomics & Bioinformatics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1672022921000772 |
Similar Items
-
Immuno-Oncology: Emerging Targets and Combination Therapies
by: Henry T. Marshall, et al.
Published: (2018-08-01) -
Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
by: Vida Vafaizadeh, et al.
Published: (2020-03-01) -
The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy
by: Jessica Michie, et al.
Published: (2020-01-01) -
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
by: Lisa H. Butterfield, et al.
Published: (2018-12-01) -
Targeting STAT3 in Cancer Immunotherapy
by: Sailan Zou, et al.
Published: (2020-09-01)